{"doi":"10.1016/j.annonc.2022.08.051","title":"LBA10 Sotorasib versus docetaxel for previously treated non-small cell lung cancer with KRAS G12C mutation: CodeBreaK 200 phase III study","abstract":null,"journal":"Annals of Oncology","year":2022,"id":623493,"datarank":2.721144963633931,"base_score":3.6888794541139363,"endowment":3.6888794541139363,"self_citation_contribution":0.5533319181170905,"citation_network_contribution":2.1678130455168407,"self_endowment_contribution":0.5533319181170905,"citer_contribution":2.1678130455168407,"corpus_percentile":null,"corpus_rank":null,"citation_count":39,"citer_count":37,"citers_with_citation_signal":33,"citers_with_endowment":33,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1611361,"name":"A.J. de Langen","orcid":null,"position":1,"is_corresponding":false},{"id":1611362,"name":"D.M. Waterhouse","orcid":null,"position":2,"is_corresponding":false},{"id":1611363,"name":"J. Mazieres","orcid":null,"position":3,"is_corresponding":false},{"id":1611364,"name":"A-M.C. Dingemans","orcid":null,"position":4,"is_corresponding":false},{"id":1518438,"name":"G. Mountzios","orcid":null,"position":5,"is_corresponding":false},{"id":1611365,"name":"M. Pless","orcid":null,"position":6,"is_corresponding":false},{"id":931668,"name":"J. Wolf","orcid":"0000-0003-1274-8297","position":7,"is_corresponding":false},{"id":996660,"name":"M. Schuler","orcid":null,"position":8,"is_corresponding":false},{"id":1572,"name":"H. Lena","orcid":null,"position":9,"is_corresponding":false},{"id":1611366,"name":"F. Skoulidis","orcid":null,"position":10,"is_corresponding":false},{"id":1611367,"name":"I. Okamoto","orcid":null,"position":11,"is_corresponding":false},{"id":1611368,"name":"S-W. Kim","orcid":null,"position":12,"is_corresponding":false},{"id":1611369,"name":"H. Linardou","orcid":null,"position":13,"is_corresponding":false},{"id":1611370,"name":"S. Novello","orcid":null,"position":14,"is_corresponding":false},{"id":1039350,"name":"Y. Chen","orcid":"0000-0002-5083-1414","position":15,"is_corresponding":false},{"id":1611371,"name":"B. Solomon","orcid":null,"position":16,"is_corresponding":false},{"id":1611372,"name":"C. Obiozor","orcid":null,"position":17,"is_corresponding":false},{"id":573664,"name":"Y. Wang","orcid":"0000-0001-9849-0682","position":18,"is_corresponding":false},{"id":1565,"name":"L. Paz-Ares","orcid":null,"position":19,"is_corresponding":false},{"id":1369841,"name":"M.L. Johnson","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"LBA10 Sotorasib versus docetaxel for previously treated non-small cell lung cancer with KRAS G12C mutation: CodeBreaK 200 phase III study","abstract":null,"is_dataset_classified":null,"base_score":3.6888794541139363,"endowment":3.6888794541139363,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19767382","pmcid":null,"openalex_id":"https://openalex.org/W4297981973","authors":[],"funders":[],"total_grants":0,"fwci":5.3066,"citation_percentile":0.96961627,"influential_citations":2,"citation_trend":[{"year":2022,"count":10},{"year":2023,"count":20},{"year":2024,"count":7},{"year":2025,"count":2}],"oa_status":"bronze","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"http://www.annalsofoncology.org/article/S0923753422039291/pdf","host_type":"journal"},{"url":"http://www.annalsofoncology.org/article/S0923753422039291/pdf","host_type":"BRONZE"},{"url":"http://www.annalsofoncology.org/article/S0923753422039291/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0923753422039291?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0923753422039291?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.annonc.2022.08.051","host_type":"journal"}],"fields_of_study":["Lung Cancer Treatments and Mutations","Cancer therapeutics and mechanisms","Lung Cancer Research Studies","Medicine"],"mesh_terms":[],"keywords":["Docetaxel","Medicine","Clinical endpoint","Internal medicine","KRAS","Oncology","Lung cancer","Phases of clinical research","Chemotherapy","Progression-free survival","Progressive disease","Cancer","Clinical trial","Colorectal cancer"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T00:07:57.670053Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}